Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.550
+0.040 (2.65%)
Jan 29, 2026, 12:38 PM EST - Market open
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $96.51 million as of January 29, 2026. Its market cap has increased by 6.07% in one year.
Market Cap
96.51M
Enterprise Value
36.84M
1-Year Change
6.07%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $96.51M, a decrease of -81.57%. That is a compound annual growth rate of -32.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 94.02M | 31.30% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dogwood Therapeutics | 105.23M |
| Inovio Pharmaceuticals | 105.12M |
| Anixa Biosciences | 102.80M |
| Cassava Sciences | 102.41M |
| MindWalk Holdings | 102.25M |
| Champions Oncology | 102.06M |
| Coya Therapeutics | 101.27M |
| Korro Bio | 101.14M |